Skip to main content

People In The News: Aug 5, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health has tapped Mahendra Rao to be director of the new Intramural Center for Regenerative Medicine (CRM). Rao formerly was VP of regenerative medicine at Life Technologies and he co-founded the neural stem cell company Q-Therapeutics. The NIH-CRM is an initiative to create a center of excellence in stem cell technology located at NIH's campus that will focus on studying and using induced pluripotent stem cells.

Rao had joined Life Tech predecessor Invitrogen in 2006 after serving as section chief for stem cells and senior investigator in the laboratory of neuroscience for the National Institute on Aging.

Arthur Feldman is leaving his post as chairman of the department of medicine at Jefferson Medical College to become executive dean of the Temple University School of Medicine and chief academic officer of Temple's Health SystembizWatch at Temple University Health System. Feldman wants to see the medical school increase multidisciplinary research in genomics and pharmacogenomics, among other areas, he said in a Temple University statement.

The University of Western Australia has named Eric Moses to be director of the Center for Genetic Epidemiology and Biostatistics, which conducts studies of the genetic and environmental causes of human diseases such as heart disease and cancer. Moses currently is head of the Texas Biomedical Research Institute in San Antonio and he formerly was head of laboratory research in the Pregnancy Research Centre at the Royal Women's Hospital in Melbourne.

The former director of the White House Office of Science and Technology Policy (OSTP) Jack Marburger died on July 28. Marburger, who served as science adviser to President George W. Bush, also was president of Stony Brook University and director of Brookhaven National Laboratory.

Molecular diagnostics company PrimeraDx has appointed Fayyaz Memon to be VP of regulatory affairs and compliance. During his career, Memon has worked in management positions at Thermo Fisher Scientific, Digene, Johnson & Johnson, and SmithKline Beecham.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.